Results of May Measurement Month 2018 campaign in Venezuela

Hernández-Hernández, Rafael; Duín, Amanda; Octavio-Seijas, José Andrés; Lopez-Rivera, J.; Morr, Igor; Silva, Eglé; Gúzman-Franolic, Mónica L; Costantini-Olmos, Antonieta P; Marval, José; Ruíz-Lugo, José Félix; Vásquez, Dámaso; Méndez-Amaya, Nedina Coromoto; Armas-Hernández, María José; Beaney, Thomas; Ster, Anca Chis; Poulter, Neil

doi:10.1093/eurheartj/suaa048

Cited by 3 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The strongest factors linked with high mean systolic/diastolic BP were known hypertension, the use of antihypertensive medication, and lower years of formal education, as previously reported. 6 , 7 By contrast, physical activity was associated with lower mean BPs. In women, pregnancy was associated with lower BPs, and in women who presented with hypertension in a previous pregnancy, both systolic and diastolic BPs were significantly higher.…”

Section: Discussionmentioning

confidence: 89%

“…In MMM21 in Venezuela, the percentage of participants with hypertension was 60.3%, which is higher than in previous MMM studies for Venezuela. 5–7 For example, in 2019, 48.9% were classified as hypertensive, 6 which may be due in small part to an older average age of 2021 screenees (56.4 vs. 54.7 years). On the other hand, sampling of MMM campaigns is opportunistic and not randomized, and it is possible that hypertensive patients participated in higher numbers than in previous years after the restrictions from the COVID-19.…”

Section: Discussionmentioning

confidence: 99%

“…In contrast, in the MMM 2017, 2018, and 2019 campaigns, a higher frequency of hypertension was reported as 48.9%, 48.4%, and 48.9%, among screened populations of mean age 53.2, 54.2, and 54.7 years, respectively. 5 , 6 , 7 …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

May Measurement Month 2021: an analysis of blood pressure screening results from Venezuela

Hernández-Hernández,

Guzmán-Franulic,

Rawik-Dagher

et al. 2024

European Heart Journal Supplements

Self Cite

View full text Add to dashboard Cite

Cardiovascular diseases continue to be the main cause of death in Venezuela, and hypertension is the principal risk factor. The May Measurement Month (MMM) campaign is a global initiative aimed to raising awareness of hypertension, which has been conducted in Venezuela since 2017. May Measurement Month 2021 included 46 732 participants with a mean age of 56.4 years (SD 14.4), 57.9% of whom were female. The percentage with hypertension was 60.3% (57.9% of females and 63.7% of males), 82.3% (84.8% of females and 79.2% of males) were aware, and 80.2% were taking antihypertensive medication. Of those on antihypertensive medication, 44.2% (41.2% of females and 48.2% of males) were not controlled [blood pressure (BP) ≥ 140/≥90 mmHg], with 61.3% receiving one drug, 30.0% two drugs, and 8.7% three or more drugs. 87.5% of those on treatment reported taking it regularly. Conditions associated with higher BP levels include fewer years of education, having a previous diagnosis of hypertension, and women who were hypertensive during a previous pregnancy. Physical activity and pregnancy were conditions associated with lower BP levels. A previous positive COVID-19 test was reported in 11.1%, and one or more COVID-19 vaccinations reported in 22.7% of participants. Of those on antihypertensive medication, 78.8% reported their treatment was not affected by COVID-19. Results are consistent with previous MMM campaigns and indicate that the screening campaign is feasible and useful to identify hypertension even in exceptional conditions such as the COVID-19 pandemic.

show abstract

Section: Discussionmentioning

confidence: 89%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

May Measurement Month 2021: an analysis of blood pressure screening results from Venezuela

Hernández-Hernández,

Guzmán-Franulic,

Rawik-Dagher

et al. 2024

European Heart Journal Supplements

Self Cite

View full text Add to dashboard Cite

show abstract

May Measurement Month 2019: an analysis of blood pressure screening results from Venezuela, Latin America

Hernández-Hernández

Poulter²,

Gúzman-Franolic

et al. 2021

European Heart Journal Supplements

View full text Add to dashboard Cite

Cardiovascular diseases are the main cause of death in Venezuela. Raised blood pressure (BP) accompanied by diabetes mellitus, obesity, lipid abnormalities, and tobacco usage are the biggest contributors to mortality. The May Measurement Month (MMM) campaign is a global initiative aimed to raising awareness of hypertension, which has been conducted in Venezuela since 2017. MMM2019 included 24 672 subjects (mean age: 54.7 years, SD 25.2, 63.1% female). The proportion with hypertension was 48.9%; 14.3% were unknown hypertensives, 35.5% of those who receiving treatment had uncontrolled hypertension (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg); when considering all hypertensives, 53.3% were controlled. Sixty per cent of those on anti-hypertensive medication were on monotherapy, 27.7% were on two, and 7.7% were on three or more drugs. Body mass index, calculated for the total population, was on average 25.6 (SD: 4.8) kg/m2. 16.2% of participants were classified as obese, 34.0% as overweight, and 4.0% were classified as underweight. Diabetes mellitus was reported by 9.4%, smoking by 7.3%, and 10.5% reported drinking alcohol regularly. Conditions associated with higher BP levels were obesity, diabetes mellitus, and women with a history of hypertension during a previous pregnancy. These results are consistent with the two previous MMM campaigns and indicate that repeated screening can routinely identify hypertension. There is an urgent need for Venezuela to implement programmes of detection, treatment, and control not only for hypertension but also for other common cardiovascular risk factors.

show abstract

2024 Latin American Society of Hypertension guidelines on the management of arterial hypertension and related comorbidities in Latin America

Sánchez,

Coca,

de Salazar

et al. 2024

Journal of Hypertension

View full text Add to dashboard Cite

Hypertension is responsible for more than two million deaths due to cardiovascular disease annually in Latin America (LATAM), of which one million occurs before 70 years of age. Hypertension is the main risk factor for cardiovascular morbidity and mortality, affecting between 20 and 40% of LATAM adults. Since the publication of the 2017 LASH hypertension guidelines, reports from different LATAM countries have confirmed the burden of hypertension on cardiovascular disease events and mortality in the region. Many studies in the region have reported and emphasized the dramatically insufficient blood pressure control. The extremely low rates of awareness, treatment, and control of hypertension, particularly in patients with metabolic disorders, is a recognized severe problem in LATAM. Earlier implementation of antihypertensive interventions and management of all cardiovascular risk factors is the recognized best strategy to improve the natural history of cardiovascular disease in LATAM. The 2024 LASH guidelines have been developed by a large group of experts from internal medicine, cardiology, nephrology, endocrinology, general medicine, geriatrics, pharmacology, and epidemiology of different countries of LATAM and Europe. A careful search for novel studies on hypertension and related diseases in LATAM, together with the new evidence that emerged since the 2017 LASH guidelines, support all statements and recommendations. This update aims to provide clear, concise, accessible, and useful recommendations for health professionals to improve awareness, treatment, and control of hypertension and associated cardiovascular risk factors in the region.

show abstract

Results of May Measurement Month 2018 campaign in Venezuela

Cited by 3 publications

References 6 publications

May Measurement Month 2021: an analysis of blood pressure screening results from Venezuela

May Measurement Month 2021: an analysis of blood pressure screening results from Venezuela

May Measurement Month 2019: an analysis of blood pressure screening results from Venezuela, Latin America

2024 Latin American Society of Hypertension guidelines on the management of arterial hypertension and related comorbidities in Latin America

Contact Info

Product

Resources

About